scholarly article | Q13442814 |
P2093 | author name string | Abdelrahim Abdrabou Sadek | |
Mohammed Abd El-Aal | |||
Ahmed Ahmed Allam | |||
Shaimaa Mohamed Mahmoud | |||
Walaa Ibrahim Abd El-Halim | |||
P2860 | cites work | Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy | Q28155823 |
Population frequencies of inherited neuromuscular diseases—A world survey | Q28266298 | ||
The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used | Q34103360 | ||
Biochemical markers of muscular damage | Q34118633 | ||
A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy | Q34417832 | ||
Current treatment of adult Duchenne muscular dystrophy | Q34554031 | ||
Therapeutic approaches to muscular dystrophy. | Q34982869 | ||
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy | Q35740280 | ||
Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies | Q36736081 | ||
Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function | Q37497985 | ||
Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management | Q37640907 | ||
Serum biomarkers as signals for risk and severity of work-related musculoskeletal injury | Q37755049 | ||
Hereditary muscular dystrophies and the heart | Q37772311 | ||
Cardiomyopathy of Duchenne muscular dystrophy: current understanding and future directions | Q37889770 | ||
Proteomic identification of biomarkers of skeletal muscle disorders. | Q38079622 | ||
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up | Q42629875 | ||
Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011. | Q43971374 | ||
Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy | Q46772360 | ||
The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy | Q46943097 | ||
Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital. | Q47896681 | ||
Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase | Q48006442 | ||
Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. | Q48530771 | ||
Patterns of left ventricular remodeling in patients with Duchenne Muscular Dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. | Q53250833 | ||
107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, the Netherlands. | Q53304609 | ||
The prevalence and prognostic significance of arrhythmias in Duchenne type muscular dystrophy | Q67464288 | ||
Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy | Q71127157 | ||
Cardiac and respiratory involvement in advanced stage Duchenne muscular dystrophy | Q71822781 | ||
Ventricular arrhythmia in Duchenne muscular dystrophy: Prevalence, significance and prognosis | Q72096780 | ||
Prolonged QT interval in hypertrophic and dilated cardiomyopathy in children | Q72688317 | ||
New normal limits for the paediatric electrocardiogram | Q73710454 | ||
Abnormalities of diastolic function precede dilated cardiomyopathy associated with Duchenne muscular dystrophy | Q79850222 | ||
Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy | Q79976391 | ||
Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life | Q80206939 | ||
Re-examination of the electrocardiogram in boys with Duchenne muscular dystrophy and correlation with its dilated cardiomyopathy | Q83142853 | ||
Correlation of heart rate and cardiac dysfunction in Duchenne muscular dystrophy | Q83705711 | ||
P433 | issue | 11 | |
P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
P304 | page(s) | 5732-5739 | |
P577 | publication date | 2017-11-25 | |
P1433 | published in | Electronic physician | Q27726126 |
P1476 | title | Evaluation of cardiac functions in children with Duchenne Muscular Dystrophy: A prospective case-control study | |
P478 | volume | 9 |
Q97528479 | DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology |
Q92510845 | Preliminary Evidences of Safety and Efficacy of Flavonoids- and Omega 3-Based Compound for Muscular Dystrophies Treatment: A Randomized Double-Blind Placebo Controlled Pilot Clinical Trial |
Search more.